116 related articles for article (PubMed ID: 29210257)
1. New EU Rules for In Vitro Diagnostic Genetic Tests, a First Step in the Right Direction.
Roscam Abbing HDC
Eur J Health Law; 2017 Apr; 24(2):121-33. PubMed ID: 29210257
[No Abstract] [Full Text] [Related]
2. Direct-to-consumer Genetic Testing: Changes in the EU Regulatory Landscape.
Slokenberga S
Eur J Health Law; 2015 Dec; 22(5):463-80. PubMed ID: 26665691
[TBL] [Abstract][Full Text] [Related]
3. A review of the legislation of direct-to-consumer genetic testing in EU member states.
Hoxhaj I; Stojanovic J; Sassano M; Acampora A; Boccia S
Eur J Med Genet; 2020 Apr; 63(4):103841. PubMed ID: 31923586
[No Abstract] [Full Text] [Related]
4. “Better Not to Know?”: Justifiable Limits on the Right to Information in the Realm of DTC Genetic Testing. An Analysis of the European and Spanish Legal Framework.
Martínez Otero JM
Eur J Health Law; 2017 Apr; 24(2):175-97. PubMed ID: 29210260
[TBL] [Abstract][Full Text] [Related]
5. Direct-to-Consumer Genetic Testing and Potential Loopholes in Protecting Consumer Privacy and Nondiscrimination.
Hendricks-Sturrup RM; Prince AER; Lu CY
JAMA; 2019 May; 321(19):1869-1870. PubMed ID: 30998825
[No Abstract] [Full Text] [Related]
6. Food and drug administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.
Yang YT; Zettler PJ
Cancer; 2019 Jan; 125(1):12-14. PubMed ID: 30387874
[No Abstract] [Full Text] [Related]
7. [Direct-to-consumer genetic testing: a regulation by the market, or a medical regulation?].
Jautrou H
Med Sci (Paris); 2020 Feb; 36(2):153-159. PubMed ID: 32129752
[TBL] [Abstract][Full Text] [Related]
8. [Advantages and disadvantages of direct-to-consumer genetic tests].
Christiansen CW; Gerdes AA
Ugeskr Laeger; 2017 Mar; 179(11):. PubMed ID: 28330535
[TBL] [Abstract][Full Text] [Related]
9. Directed to consumer genetic testing. Perspective from the Ethics commission of the Spanish Society for Human Genetics.
Pàmpols Ros T; García Sagredo JM; Pérez Aytés A; Díaz de Bustamante A
Med Clin (Barc); 2019 Jul; 153(1):35-40. PubMed ID: 30898448
[No Abstract] [Full Text] [Related]
10. Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
Bates M
IEEE Pulse; 2018; 9(6):11-14. PubMed ID: 30452341
[TBL] [Abstract][Full Text] [Related]
11. Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.
Gollust SE; Gray SW; Carere DA; Koenig BA; Lehmann LS; McGUIRE AL; Sharp RR; Spector-Bagdady K; Wang NA; Green RC; Roberts JS;
Milbank Q; 2017 Jun; 95(2):291-318. PubMed ID: 28589610
[TBL] [Abstract][Full Text] [Related]
12. Return of raw data in genomic testing and research: ownership, partnership, and risk-benefit.
May T; Nakano-Okuno M; Kelley WV; East K; Moss IP; Sodeke S; Korf B; Barsh G
Genet Med; 2020 Jan; 22(1):12-14. PubMed ID: 31312044
[No Abstract] [Full Text] [Related]
13. Which lessons can we learn from the European Union legal framework of medicines for the regulation of direct-to-consumer genetic tests?
van Hellemondt R; Hendriks A; Breuning M
Rev Derecho Genoma Hum; 2012; (36):99-120. PubMed ID: 23115825
[TBL] [Abstract][Full Text] [Related]
14. Patients Armed With Their Own Genetic Data Raise Tough Questions.
Storrs C
Health Aff (Millwood); 2018 May; 37(5):690-693. PubMed ID: 29733706
[TBL] [Abstract][Full Text] [Related]
15. Country Reports.
Zawati MH; Chalmers D; Dallari SG; de Neiva Borba M; Pinkesz M; Joly Y; Chen H; Hartlev M; Leitsalu L; Soini S; Rial-Sebbag E; Hoppe N; Garani-Papadatos T; Vidalis P; Srinivas KR; Siegal G; Negri S; Hatanaka R; Al-Hussaini M; Al-Tabba' A; Motta-Murgía L; Moran LET; Hendriks A; Nnamuchi O; Isasi R; Krekora-Zajac D; Sadoun E; Ho C; Andanda P; Lee WB; Nicolás P; Mattsson T; Talanova V; Dosch A; Sprumont D; Fan CT; Hung TH; Nnamuchi O; Kaye J; Phillips A; Gowans H; Shah N; Hazel JW
J Law Med Ethics; 2019 Dec; 47(4):582-704. PubMed ID: 31957584
[No Abstract] [Full Text] [Related]
16. Direct-to-consumer misleading information on cancer risks calls for an urgent clarification of health genetic testing performed by commercial companies.
de Pauw A; Schwartz M; Colas C; Golmard L; Stoppa-Lyonnet D
Eur J Cancer; 2020 Jun; 132():100-103. PubMed ID: 32335476
[TBL] [Abstract][Full Text] [Related]
17. Regulating the advertising of genetic tests in Europe: a balancing act.
Kalokairinou L; Borry P; Howard HC
J Med Genet; 2017 Oct; 54(10):651-656. PubMed ID: 28735297
[TBL] [Abstract][Full Text] [Related]
18. Growing complexity of (expanded) carrier screening: Direct-to-consumer, physician-mediated, and clinic-based offers.
Chokoshvili D; Vears DF; Borry P
Best Pract Res Clin Obstet Gynaecol; 2017 Oct; 44():57-67. PubMed ID: 28302443
[TBL] [Abstract][Full Text] [Related]
19. Current landscape of direct-to-consumer genetic testing and its role in ophthalmology: a review.
Sanfilippo PG; Kearns LS; Wright P; Mackey DA; Hewitt AW
Clin Exp Ophthalmol; 2015 Aug; 43(6):578-90. PubMed ID: 25676199
[TBL] [Abstract][Full Text] [Related]
20. Challenges raised by cross-border testing of rare diseases in the European union.
Pohjola P; Hedley V; Bushby K; Kääriäinen H
Eur J Hum Genet; 2016 Nov; 24(11):1547-1552. PubMed ID: 27381091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
